Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2012 Sep;19(9):2814-21. doi: 10.1245/s10434-012-2321-7. Epub 2012 Apr 4.
We evaluated clinical features and survival outcomes among patients with signet ring and mucinous histologies of colorectal adenocarcinoma by using data from the National Cancer Data Base (NCDB).
Patients aged 18-90 years with colorectal adenocarcinoma diagnosed between 1998 and 2002 were identified from the NCDB. Site-stratified (colon vs. rectum) survival analysis was performed by multivariate relative survival adjusted for multiple clinicopathologic and treatment variables.
The study included 244,794 patients: 25,546 (10%) with mucinous, 2,260 (1%) with signet ring, and 216,988 (89%) with nonmucinous, non-signet ring adenocarcinoma. Mucinous and signet ring cancers were more frequently right-sided (60% and 62%, respectively) than were nonmucinous, non-signet ring adenocarcinomas (42%, P < 0.001). Signet ring histology was associated with a higher stage (P < 0.001), and 77.2% of signet ring tumors were high-grade lesions, compared with 20% of mucinous and 17% of non-signet ring, nonmucinous adenocarcinomas (P < 0.001). After adjustment for covariates, signet ring histology was independently associated with higher risk of death [hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.33-1.51, and HR 1.57, CI 1.38-1.77, for tumors located in the colon and rectum, respectively]. Mucinous tumors of the rectum (HR 1.22, CI 1.16-1.29), but not the colon (HR 1.03, CI 1.00-1.06), were associated with increased risk of death.
Signet ring cell adenocarcinomas of the colon and rectum and mucinous adenocarcinomas of the rectum are associated with poorer survival. These aggressive histologic variants of colorectal adenocarcinoma should be targeted for research initiatives to improve outcomes.
我们利用国家癌症数据库(NCDB)的数据,评估了具有结直肠腺癌印戒细胞和黏液组织学特征的患者的临床特征和生存结局。
从 NCDB 中确定了 1998 年至 2002 年间诊断为结直肠腺癌且年龄在 18-90 岁之间的患者。通过多变量相对生存分析,对多个临床病理和治疗变量进行调整,对结直肠部位(结肠与直肠)的生存情况进行分析。
本研究共纳入 244794 例患者:25546 例(10%)为黏液性,2260 例(1%)为印戒细胞型,216988 例(89%)为非黏液性、非印戒细胞型腺癌。黏液性和印戒细胞癌更常发生在右侧(分别为 60%和 62%),而非黏液性、非印戒细胞型腺癌则为 42%(P<0.001)。印戒细胞组织学与较高的分期相关(P<0.001),77.2%的印戒细胞肿瘤为高级别病变,而黏液性肿瘤为 20%,非印戒细胞、非黏液性腺癌为 17%(P<0.001)。在调整协变量后,印戒细胞组织学与死亡风险增加独立相关[结肠肿瘤的危险比(HR)为 1.42,95%置信区间(CI)为 1.33-1.51;直肠肿瘤的 HR 为 1.57,CI 为 1.38-1.77]。直肠的黏液性肿瘤(HR 1.22,CI 1.16-1.29),而不是结肠的黏液性肿瘤(HR 1.03,CI 1.00-1.06),与死亡风险增加相关。
结肠和直肠的印戒细胞腺癌以及直肠的黏液腺癌与生存率降低相关。这些结直肠腺癌侵袭性组织学变异型应作为研究目标,以改善预后。